Report cover image

Pregabalin Market by Dosage Forms (Extended Release, Oral Capsule, Oral Solution), Drug Class (Anticonvulsants, Fibromyalgia Agents), Application, End-Users, Distribution Channel - Global Forecast 2024-2030

Publisher 360iResearch
Published Jan 15, 2024
Length 184 Pages
SKU # IRE18449298

Description

Pregabalin Market by Dosage Forms (Extended Release, Oral Capsule, Oral Solution), Drug Class (Anticonvulsants, Fibromyalgia Agents), Application, End-Users, Distribution Channel - Global Forecast 2024-2030


The Pregabalin Market size was estimated at USD 1.12 billion in 2023 and expected to reach USD 1.20 billion in 2024, at a CAGR 7.74% to reach USD 1.89 billion by 2030.

Global Pregabalin Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Pregabalin Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pregabalin Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Pregabalin Market, highlighting leading vendors and their innovative profiles. These include Almelo Private Limited, Amneal Pharmaceuticals LLC, Aurobindo Pharma Limited, BAL Pharma Ltd., Cipla Limited, Dongbang FTL, Genesis Biotec Inc., Hikal Ltd., Lupin Limited, Medley Pharmaceuticals Limited, Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., and Zydus Lifesciences Limited.

Market Segmentation & Coverage

This research report categorizes the Pregabalin Market to forecast the revenues and analyze trends in each of the following sub-markets:

Dosage Forms
Extended Release
Oral Capsule
Oral Solution
Oral Tablet
Drug Class
Anticonvulsants
Fibromyalgia Agents
Application
Anxiety Disorder
Epilepsy
Neuropathic Pain
End-Users
Homecare
Hospitals
Research institute
Specialty Clinics
Distribution Channel
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Pregabalin Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pregabalin Market?
3. What are the technology trends and regulatory frameworks in the Pregabalin Market?
4. What is the market share of the leading vendors in the Pregabalin Market?
5. Which modes and strategic moves are suitable for entering the Pregabalin Market?

Note: PDF & Excel + Online Access - 1 Year

Table of Contents

184 Pages
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Pregabalin Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing cases of epilepsy and anxiety disorders
5.1.1.2. Favorable government initiatives for raising awareness for anxiety issues
5.1.1.3. Rising geriartic population with neuropathic pain
5.1.2. Restraints
5.1.2.1. Presence of substitutes and lack of awareness
5.1.3. Opportunities
5.1.3.1. Rising approvals of generic versions of the medicine
5.1.3.2. Advancements and product enhancements for pregabalin
5.1.4. Challenges
5.1.4.1. Adverse effects on health and product recalls
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Pregabalin Market, by Dosage Forms
6.1. Introduction
6.2. Extended Release
6.3. Oral Capsule
6.4. Oral Solution
6.5. Oral Tablet
7. Pregabalin Market, by Drug Class
7.1. Introduction
7.2. Anticonvulsants
7.3. Fibromyalgia Agents
8. Pregabalin Market, by Application
8.1. Introduction
8.2. Anxiety Disorder
8.3. Epilepsy
8.4. Neuropathic Pain
9. Pregabalin Market, by End-Users
9.1. Introduction
9.2. Homecare
9.3. Hospitals
9.4. Research institute
9.5. Specialty Clinics
10. Pregabalin Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.4. Retail Pharmacy
11. Americas Pregabalin Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Pregabalin Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Pregabalin Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. Almelo Private Limited
15.1.2. Amneal Pharmaceuticals LLC
15.1.3. Aurobindo Pharma Limited
15.1.4. BAL Pharma Ltd.
15.1.5. Cipla Limited
15.1.6. Dongbang FTL
15.1.7. Genesis Biotec Inc.
15.1.8. Hikal Ltd.
15.1.9. Lupin Limited
15.1.10. Medley Pharmaceuticals Limited
15.1.11. Novartis AG
15.1.12. Pfizer Inc.
15.1.13. Teva Pharmaceutical Industries Ltd.
15.1.14. Torrent Pharmaceuticals Ltd.
15.1.15. Zydus Lifesciences Limited
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
FIGURE 1. PREGABALIN MARKET RESEARCH PROCESS
FIGURE 2. PREGABALIN MARKET SIZE, 2023 VS 2030
FIGURE 3. PREGABALIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PREGABALIN MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. PREGABALIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PREGABALIN MARKET DYNAMICS
FIGURE 7. PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2023 VS 2030 (%)
FIGURE 8. PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. PREGABALIN MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
FIGURE 10. PREGABALIN MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. PREGABALIN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. PREGABALIN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. PREGABALIN MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
FIGURE 14. PREGABALIN MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 16. PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS PREGABALIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS PREGABALIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES PREGABALIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES PREGABALIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. PREGABALIN MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. PREGABALIN MARKET SHARE, BY KEY PLAYER, 2023

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us